MedPath

statin

Generic Name
statin
Clinical Trials
Related News

Epidemiology, Management, Prognosis and Medical Cost Analysis of IHCA and OHCA

Completed
Conditions
Out-Of-Hospital Cardiac Arrest
Interventions
First Posted Date
2018-09-26
Last Posted Date
2018-09-26
Lead Sponsor
National Taiwan University Hospital
Target Recruit Count
100000
Registration Number
NCT03684616
Locations
🇨🇳

National Taiwan University Hospital, Taipei, Taiwan

Lipid-lowering Effects of Gefarnate in Statin-treated Coronary Heart Disease Patients With Residual Hypertriglyceridemia

Phase 2
Conditions
Coronary Artery Disease
Interventions
First Posted Date
2018-08-01
Last Posted Date
2020-07-30
Lead Sponsor
First Affiliated Hospital of Harbin Medical University
Target Recruit Count
70
Registration Number
NCT03610321
Locations
🇨🇳

the first affiliated hospital of Harbin medical university, Harbin, Heilongjiang, China

Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study

Phase 2
Conditions
Dyslipidemias
LDL Hyperlipoproteinemia
Interventions
Drug: Red Rice Yeast Extract
First Posted Date
2018-07-31
Last Posted Date
2019-10-08
Lead Sponsor
Saint-Joseph University
Target Recruit Count
40
Registration Number
NCT03607383
Locations
🇱🇧

Saint Anthony Primary Care Center, Jdeide, Lebanon

Primary Prevention With Statin and Incidence of Recurrent MI and Cardiogenic Shock in Post-ACS Patients

Completed
Conditions
Recurrent Myocardial Infarction
Cardiogenic Shock
Acute Coronary Syndrome
Interventions
First Posted Date
2018-07-24
Last Posted Date
2018-09-12
Lead Sponsor
Tarumanagara University
Target Recruit Count
145
Registration Number
NCT03596944
Locations
🇮🇩

Cengkareng General Hospital, Jakarta, DKI Jakarta, Indonesia

Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation

Completed
Conditions
Hepatocellular Carcinoma
Interventions
First Posted Date
2018-04-06
Last Posted Date
2018-04-06
Lead Sponsor
Yonsei University
Target Recruit Count
350
Registration Number
NCT03490461
Locations
🇰🇷

Division of Endocrinology and Metabolism Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

Endothelial Function Evaluation in Patients With PAOD Treated With Sulodexide + Conventional Treatment (CT) Vs CT Alone

Phase 3
Conditions
Peripheral Arterial Obstructive Disease
Interventions
Drug: Antiplatelet Agents
Drug: ACE inhibitor
First Posted Date
2017-12-12
Last Posted Date
2019-12-02
Lead Sponsor
Alfa Wassermann Tunisia
Target Recruit Count
156
Registration Number
NCT03370705
Locations
🇹🇳

InvSite Poseidon 0022, Sousse, Tunisia

🇹🇳

InvSite Poseidon0031, Sfax, Tunisia

🇹🇳

InvSite Poseidon0011, Tunis, Tunisia

ANti-Oxidant in Variant Angina (ANOVA) Trial

Phase 4
Conditions
Variant Angina
Interventions
Drug: Vitamin C and Vitamin E
Drug: Standard medication for variant angina
First Posted Date
2017-07-24
Last Posted Date
2017-07-24
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
300
Registration Number
NCT03228238
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

A Project to Improve the Diagnosis and Prognosis of Myocardial Injury Associated to Non Cardiac Surgery

Completed
Conditions
Myocardium; Injury
Interventions
Diagnostic Test: Troponin
First Posted Date
2017-04-28
Last Posted Date
2022-03-22
Lead Sponsor
Parc de Salut Mar
Target Recruit Count
800
Registration Number
NCT03133260
Locations
🇪🇸

Hospital Del Mar, Barcelona, Spain

The Effect of Anacetrapib on Vascular Function and Arterial Stiffness

Completed
Conditions
Atherosclerotic Cardiovascular Disease
Vascular Disease
Interventions
Drug: Placebo
First Posted Date
2016-10-12
Last Posted Date
2024-02-07
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Target Recruit Count
103
Registration Number
NCT02931188
Locations
🇬🇧

Clinical Investigation Ward, Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom

Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and Outcomes

Phase 3
Completed
Conditions
Carotid Artery Stenosis
Strokes
Interventions
Other: Placebo
First Posted Date
2016-07-29
Last Posted Date
2022-11-04
Lead Sponsor
Columbia University
Target Recruit Count
31
Registration Number
NCT02850081
Locations
🇺🇸

Albany Medical College/The Vascular Group at Albany, Albany, New York, United States

🇺🇸

Valley Hospital, Ridgewood, New Jersey, United States

🇺🇸

State University of New York at Buffalo, Buffalo, New York, United States

and more 4 locations
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy